GlassScriptPhysician profile
Krupa Patel
NPI 1548035587
$2,334.77
in general payments reported to CMS, 2019-2025
14 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,781 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Travel and Lodging: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.84 |
| Travel and Lodging | $426.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $823.71 | 2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $373.81 | 2024-2025 | Verquvo, Gardasil 9, Capvaxive |
| Amgen INC. | $309.34 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.39 | 2024-2025 | Jardiance |
| Atricure, INC. | $152.50 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Lilly USA, LLC | $143.04 | 2024-2025 | Zepbound, Mounjaro |
| Phathom Pharmaceuticals, INC. | $69.94 | 2024 | Voquezna |
| Novo Nordisk INC | $50.05 | 2024-2025 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $47.73 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $44.77 | 2024 | Breztri, Airsupra |
| Ardelyx, INC. | $29.47 | 2024 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $23.66 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.52 | 2024 | Entyvio |
| Novartis Pharmaceuticals Corporation | $17.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krupa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.